2024 Midterm Review

In CND resolution 66/1, entitled “Preparations for the midterm review to be held during the sixty-seventh session of the Commission on Narcotic Drugs, in 2024”, the Commission decided to focus the midterm review on taking stock of the implementation of all existing international drug policy commitments and the work to accelerate the implementation of the commitments from 2024 to 2029.

The resolution 66/1 further underscores the important role played by all relevant stakeholders in the implementation of the drug policy commitments.

In this regard, stakeholders, including UN entities, international and regional organizations, as well as NGOs in consultative status with ECOSOC, were invited to submit written contributions on the 11 challenges identified in the 2019 Ministerial Declaration, to inform the preparatory process in the lead-up to 2024. Contributions have been posted here as received, and the content remains the responsibility of the submitting entities.

The Secretariat to the CND organized a series of Engaging Minds Fireside Chats on Drug Policy to support stakeholder engagement in the lead up to the 2024 midterm review.

The informal discussions with civil society, scientists and youth were organized in the margins of the CND December Thematic Discussions.

4 December 2023 – CIVIL SOCIETY (Watch recording)

Steve Rolles, Senior Policy Analyst, Transform Drug Policy Foundation

Regina Mattson, Secretary-General, World Federation Against Drugs

5 December 2023 - SCIENTSTS (Watch recording)

Marica Ferri, European Monitoring Centre for Drugs and Drug Addiction

Thomas Clausen, Norwegian Centre for Addiction Research

6 December 2023 - YOUTH (Watch Recording)

Sarah Jul-Rasmussen, Former President Juvente Norway

Alexandra Bravo Schroth, Clinical Psychologist, University of Peru

View Photos

Concept note and programme

Presentations/Statements:

Statistical Commission

What is the 2024 Midterm Review?

The 2024 Midterm Review, held from 14-15 March 2024, served to assess progress made in the implementation of all international drug policy commitments as set forth in the 2019 Ministerial Declaration. Preceding the 2024 midterm review was a comprehensive stock-taking of all 11 challenges related to the world drug problem identified in the Ministerial Declaration, which took place during the thematic discussions held on 23-25 October and 4-6 December 2023. This comprehensive stock-taking complements the thematic discussions held by the Commission since 2019. An end-of-cycle review of the implementation of all international drug policy commitments is planned for 2029.

The midterm review was held on 14-15 March 2024, in Vienna and online. Through resolution 66/1, the Commission decided how the 2024 midterm review would take place.

The Commission agreed to work in good faith towards adopting a concise, action-oriented document at the opening of the high-level segment of its sixty-seventh session. This document would focus on taking stock of the implementation of all existing international drug policy commitments between 2019 and 2023, and on indicating the work to be done to accelerate the implementation of all those existing commitments between 2024 and 2029.

More details on the modalities of the 2024 midterm review are available in resolution 66/1.